BNGO

Bionano Genomics, Inc. develops and provides optical genome mapping (OGM) solutions that enable the detection and analysis of structural variants in genomic data. Its primary products include the Stratys™ System and Saphyr® System, which facilitate the comprehensive identification of genomic variations relevant to cancer and genetic diseases. The company serves clinical, research, and therapeutic markets, focusing on oncology, genetic diseases, and cell bioprocessing, and operates globally to enhance genomic analysis and interpretation.